Biggest News Aggregation in the World
📰 D News

Page 1077 - D News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from D. Real-time updates on events, politics, business and more.

Courier Capital LLC Reduces Stake in Dominion Energy, Inc. (NYSE:D)

Courier Capital LLC lowered its holdings in Dominion Energy, Inc. (NYSE:D – Free Report) by 1.5% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 38,485 shares of the utilities provider’s stock after selling 574 shares during the period. Courier Capital LLC’s holdings in Dominion Energy were worth $1,719,000 at the end of the […]
North Carolina United States South Carolina Dvisit Holdingschannel Diane Leopold Covestor Ltd
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Development of EHR-Integrated Cancer Staging Module Identifies Barriers, Increases Discrete Capture

The implementation and subsequent optimization of a health information technology module within the electronic health record has allowed clinicians across a diverse health care system to identify barriers to improve discrete capture of cancer staging and design solutions to address them.
Neelima Vidula Northwestern University Jeffrey Peppercorn Six Sigma Address Drivers Poor Performance

Benjamin Renner 'Draws' on His 2D Background to Make the 3DCG 'Migration'

For the Oscar-nominated director, the move from small, intimate films like ‘Ernest & Celestine’ to a major studio production meant learning to rely on a much bigger team and find new ways to communicate story ideas, designs, gags, and creative sensibilities; produced by Illumination CEO and founder Chris Meledandri, the film hits theaters today, December 22.   
New York United States Tresi Gazal Danny Devito Benjamin Renner Ernest Celestine
Source: awn.com

Patritumab Deruxtecan BLA Receives Priority Review in NSCLC

The FDA has accepted and granted priority review to the biologics license application seeking the approval of the HER3-directed antibody-drug conjugate patritumab deruxtecan for the treatment of adult patients with locally advanced or metastatic EGFR-mutated non–small cell lung cancer.
Ken Takeshita Daiichi Sankyo Global Clinical Development Merck Research Laboratories Senior Vice President Late Stage Oncology

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science